ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Camurus and Braeburn Announce Positive Top-line Results from Phase 3 Safety Study of CAM2038
May 03, 2017Camurus and Braeburn Pharmaceuticals announced positive top-line results from a long-term Phase 3 trial supporting the safety and efficacy of CAM2038 (weekly and monthly buprenorphine depots) in patients with moderate-to-severe opioid use disorder. -
Opioid Use by Iraq, Afghanistan War Vets Mirrors Rest of U.S.: Study
April 28, 2017U.S. veterans of the Iraq and Afghanistan wars use opioid painkillers at rates similar to that of the general population, a new study finds. -
Opioid Dependence Can Start in Just a Few Days
March 17, 2017Doctors who limit the supply of opioids they prescribe to three days or less may help patients avoid the dangers of dependence and addiction, a new study suggests. -
Trinity Health and Pacira Pharmaceuticals Announce Collaboration to Decrease Opioid Use
March 17, 2017Trinity Health, one of the largest hospital systems in the nation, and Pacira Pharmaceuticals announced they will collaborate to develop an alternative approach to opioids for pain management.
Pharma Sources Insight January 2025
